Uploaded September 2024 | Updated September 2026, 2 weeks ago
Dr. Nat Lenzo: https://iconcancercentre.com.au/doctor/nat-lenzo/
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:45 Who is Nat Lenzo?
2:20 Targeted therapy success?
3:30 What are these companies/treatments?
5:39 Where are these new Theranostic centers?
6:03 Can patients contact Icon Group?
7:45 Can you define Theranostics and Nuclear Oncology?
9:40 How do you get a therapeutic agent to bind to the imaging agent?
11:37 What about Pluvicto?
12:12 Safety and tolerability?
14:02 What about Actinium?
15:50 Does Lutetium really work for one-third of patients?
19:30 Is Actinium a more potent isotope? Are there more side effects?
22:00 What test do you use for Lutetium and Actinium treatment?
23:30 What is eGFR?
25:55 Is BRCA testing recommended?
26:36 When is a Theranostic treatment most optimal?
30:00 What does positive BRCA testing mean?
31:05 Actinium vs. Lutetium results?
33:34 Actinium vs. Lutetium side effects?
35:05 What kind of PSA decline do you see with Actinium?
37:07 Where does Lead fit into all this?
40:09 How does the flux directly affect the patient?
41:43 Is there a direct way for patients to find trials? clinical trials.gov and a theranostics website?
42:35 What is Standard Uptake Value (SUV) and how significant is it to prostate cancer?
45:45 What are antibodies and how can they fight cancer?
49:21 What do antibody side effects look like?
50:42 Can antibodies work with other treatments?
51:37 Treatments for PSMA negative patients?
54:48 Are there any current trials with these multiple therapies?
55:37 Prostate Global coming to the United States using radio antibody
55:58 Alex's closing remarks
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Find Clinical Trials: clinicaltrials.gov
Icon Group: https://icongroup.global/en/
Learn more about Theranostics: thno.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Dr. Nat Lenzo: https://iconcancercentre.com.au/doctor/nat-lenzo/
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:45 Who is Nat Lenzo?
2:20 Targeted therapy success?
3:30 What are these companies/treatments?
5:39 Where are these new Theranostic centers?
6:03 Can patients contact Icon Group?
7:45 Can you define Theranostics and Nuclear Oncology?
9:40 How do you get a therapeutic agent to bind to the imaging agent?
11:37 What about Pluvicto?
12:12 Safety and tolerability?
14:02 What about Actinium?
15:50 Does Lutetium really work for one-third of patients?
19:30 Is Actinium a more potent isotope? Are there more side effects?
22:00 What test do you use for Lutetium and Actinium treatment?
23:30 What is eGFR?
25:55 Is BRCA testing recommended?
26:36 When is a Theranostic treatment most optimal?
30:00 What does positive BRCA testing mean?
31:05 Actinium vs. Lutetium results?
33:34 Actinium vs. Lutetium side effects?
35:05 What kind of PSA decline do you see with Actinium?
37:07 Where does Lead fit into all this?
40:09 How does the flux directly affect the patient?
41:43 Is there a direct way for patients to find trials? clinical trials.gov and a theranostics website?
42:35 What is Standard Uptake Value (SUV) and how significant is it to prostate cancer?
45:45 What are antibodies and how can they fight cancer?
49:21 What do antibody side effects look like?
50:42 Can antibodies work with other treatments?
51:37 Treatments for PSMA negative patients?
54:48 Are there any current trials with these multiple therapies?
55:37 Prostate Global coming to the United States using radio antibody
55:58 Alex's closing remarks
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Find Clinical Trials: clinicaltrials.gov
Icon Group: https://icongroup.global/en/
Learn more about Theranostics: thno.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
